OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of OX40–OX40L Axis in the Pathogenesis of Atopic Dermatitis
Natale Schettini, Lucrezia Pacetti, Monica Corazza, et al.
Dermatitis (2024)
Closed Access | Times Cited: 5
Natale Schettini, Lucrezia Pacetti, Monica Corazza, et al.
Dermatitis (2024)
Closed Access | Times Cited: 5
Showing 5 citing articles:
Future Directions and Pipeline Therapies for Hidradenitis Suppurativa
Kim Thuy Nguyen, Daniella Jaguan, Noah Goldfarb
Dermatologic Clinics (2025) Vol. 43, Iss. 2, pp. 359-371
Closed Access
Kim Thuy Nguyen, Daniella Jaguan, Noah Goldfarb
Dermatologic Clinics (2025) Vol. 43, Iss. 2, pp. 359-371
Closed Access
Enhanced co-expression of TIGIT and PD-1 on γδ T cells correlates with clinical features and laboratory parameters in patients with primary Sjögren’s syndrome
Saizhe Song, Yanhong Yang, Tian Ren, et al.
Clinical Rheumatology (2025)
Closed Access
Saizhe Song, Yanhong Yang, Tian Ren, et al.
Clinical Rheumatology (2025)
Closed Access
Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis
Sampson Listowell Abu, Navpreet K. Hehar, DeGaulle I. Chigbu
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 5, pp. 380-389
Closed Access | Times Cited: 1
Sampson Listowell Abu, Navpreet K. Hehar, DeGaulle I. Chigbu
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 5, pp. 380-389
Closed Access | Times Cited: 1
Time of Day of Biological Treatment Administration and Outcomes in Atopic Dermatitis: Results from a Preliminary Retrospective Study
Alessandro Borghi, Maria Elena Flacco, Chiara Bocchi, et al.
Dermatitis (2024)
Closed Access | Times Cited: 1
Alessandro Borghi, Maria Elena Flacco, Chiara Bocchi, et al.
Dermatitis (2024)
Closed Access | Times Cited: 1
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
Stephan Weidinger, Andrew Blauvelt, Kim Papp, et al.
Journal of Allergy and Clinical Immunology (2024)
Open Access
Stephan Weidinger, Andrew Blauvelt, Kim Papp, et al.
Journal of Allergy and Clinical Immunology (2024)
Open Access
